Complications in Process Simulation Execution

Article

PharmTech Sponsored eBooks

PharmTech Sponsored eBooksPharmTech Sponsored eBooks-05-01-2020
Volume Sponsored eBook
Issue 6
Pages: 44–45,58

Regulators have exaggerated expectations for simulated media fills.

In the late 1970s, media fill studies began to be used in aseptic processing for the expressed purpose of evaluating sterility assurance levels in filling activities. These initial studies were simplistic. In response to regulatory expectations, the activity grew in sophistication to address perceived vulnerabilities (1). 

Read this article in Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing, May 2020, May 2020 Pages: 10–14

Article details

Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 10–14

Citation 

When referring to this article, please cite it as J. Agalloco,  “Complications in Process Simulation Execution," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

 

 

Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
CPHI Milan 2024: Compliance and Automation in Aseptic Processing
Mary Van Gaasbeck, technical services specialist, LS Equipment and Services, STERIS Life Sciences | Image Credit: Pharmaceutical Technology
Christa Myers, CRB Group; Nadiyra Walker Speight, Fujifilm Diosynth Biotechnologies
Related Content